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Abstract
The saphenous vein (SV) is the most commonly used conduit for revascularization in patients undergoing coronary artery
bypass surgery (CABG). The patency rate of this vessel is inferior to the internal thoracic artery (ITA). In the majority of
CABG procedures the ITA is removed with its outer pedicle intact whereas the (human) SV (hSV) is harvested with pedicle
removed. The vasa vasorum, a microvessel network providing the adventitia and media with oxygen and nutrients, is more
pronounced and penetrates deeper towards the lumen in veins than in arteries. When prepared in conventional CABG the
vascular trauma caused when removing the hSV pedicle damages the vasa vasorum, a situation affecting transmural flow
potentially impacting on graft performance. In patients, where the hSV is harvested with pedicle intact, the vasa vasorum is
preserved and transmural blood flow restored at graft insertion and completion of CABG. Bymaintaining blood supply to the
hSV wall, apart from oxygen and nutrients, the vasa vasorum may also transport factors potentially beneficial to graft
performance. Studies, using either corrosion casts or India ink, have shown the course of vasa vasorum in animal SV as
well as in hSV. In addition, there is some evidence that vasa vasorum of hSV terminate in the vessel lumen based on ex vivo
perfusion, histological and ultrastructural studies. This review describes the preparation of the hSV as a bypass conduit in
CABG and its performance compared with the ITA as well as how and why its patency might be improved by harvesting with
minimal trauma in a way that preserves an intact vasa vasorum.
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ANGPT-2 Angiopoietin 2
CABG Coronary artery bypass graft surgery
CT Conventional method of harvesting
EVH Endoscopic vein harvesting
FGF-2 Fibroblast growth factor 2
HIF-1 Hypoxia-inducible factor 1
hNTSVG Human no-touch saphenous vein graft
hSV Human saphenous vein
hSVG Human saphenous vein graft
ITA Internal thoracic artery
NO nitric oxide
NOS Nitric oxide synthase
NT No-touch method of harvesting
NTSVG No-touch saphenous vein graft
PDGF-B Platelet-derived growth factor B
PLGF Placental growth factor
PVAT Perivascular adipose tissue
PVF Perivascular fat
RA Radial artery
ROM Reactive oxygen metabolites
ROS Reactive oxygen species
SCF Stem cell factor
SDF-1 Stromal cell-derived factor 1
SV Saphenous vein
VEGF Vascular endothelial growth factor
VSMC Vascular smooth muscle cell
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The saphenous vein as a bypass conduit
In a recent issue of Nature Reviews in Cardiology de Vries
and colleagues discuss the use of the saphenous vein (SV) as a
conduit for surgical revascularization in patients undergoing
coronary artery bypass graft surgery (CABG) (de Vries et al.
2016). In their review the authors comment on the high failure
rate of human SV (hSV) grafts, studies into underlying causes
of graft failure and recent therapeutic options aimed at im-
proving graft patency. The hSV is the most commonly used
conduit for CABG with the other main conduits being the
internal thoracic artery (ITA) and radial artery (RA). The
hSV is the conduit of choice since it is expendable, as deeper
vessels maintain blood flow to superficial tissues after its re-
moval, the extensive length (potentially 60 cm, ~30 cm from
each leg) of this vein allows for multiple grafts and its super-
ficial position renders it easily accessible (Tsui and Dashwood
2002). A recent Perspective in the New England Journal of
Medicine, (Jones 2017) highlights the important contribution
of the Argentinian cardiac surgeon, Rene Favaloro, who in-
troduced the hSV as a conduit for coronary revascularization
in 1968 (Favaloro 1968). In general, both the arterial grafts are
harvested with their outer pedicle of tissue intact whereas,
according to Favaloro’s original instructions, BCare must be
taken to dissect only the vein, avoiding as much as possible
the adventitia that surrounds it^ (Favaloro 1969). This is now
the most commonly used, ‘conventional’ (CT), method
employed by the majority of cardiac surgeons worldwide
and, when harvesting the hSV this way, the vessel’s outer
pedicle of fat is removed. In addition, the adventitia is stripped
or damaged causing trauma that most likely affects both early-
and long-term graft patency. An atraumatic, no-touch (NT),
method of harvesting the hSV was introduced over two de-
cades ago where the hSV is removed complete with its sur-
rounding cushion of fat intact and the adventitia intact and
undamaged (Souza 1996). Here, Fig. 1 demonstrates exam-
ples of NT and CT graft preparations of hSV for CABG. No
touch hSV grafts (NTSVGs) have an improved patency over
CT hSV and are comparable to the ITA at up to 16 years
follow up (Samano et al. 2015). A major factor suggested to
explain this observation is that NTSVG preparations do not go
into spasm since there is no direct handling of the hSV by
surgical instruments, high pressure intralumenal saline disten-
sion is not required and endothelial and vascular smooth mus-
cle cell (VSMC) damage is reduced (Souza 1996; Souza et al.
1999; Tsui et al. 2001; Ahmed et al. 2004; Vasilakis et al.
2004; Verma et al. 2014). Preservation of an intact endotheli-
um and endothelium-derived nitric oxide (NO) is suggested to
account for abolition of spasm at harvesting, reduced platelet
aggregation/thrombus formation (early graft occlusion) and
reduced neointimal hyperplasia (mid-term occlusion) (Tsui
et al. 2001, 2002). The minimised surgical trauma preserves
the shape and phenotype of VSMCs thus impacting on prolif-
eration, neointimal hyperplasia and atheroma formation
(Ahmed et al. 2004; Verma et al. 2014).
Saphenous vein vasa vasorum
An interesting observation made at completion of NTSVG
insertion and proximal graft anastomosis is the retrograde fill-
ing of the adventitial vasa vasorum at removal of vascular
clamps (Souza et al. 1999). This immediate restoration of
blood supply has been suggested to restore/preserve
transmural flow, contributing to the maintenance of a ‘healthy’
graft (Dashwood and Tsui 2013). Also, since the explanted
hSV graft is disconnected at both distal and proximal ends,
filling of the vasa vasorum is most likely via terminations in
the vein lumen and tributaries. Indeed, there are studies in
support of such an arrangement of vasa terminations in
Fig. 1 Human SV graft
preparations harvested by no-
touch (a) and conventional (b)
techniques; white arrow indicate
the vein, while the black arrow
points to perivascular fat (PVF),
which has been removed in (b).
(Modified from a Dashwood et
al., Interact Cardiovasc Thorac




Academic, and b from Souza et
al., J Thorac Cardiovasc Surg
2006, 132 (2):373–378 with
acknowledgement of Elsevier)
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parental vein lumen. For example, luminal vasa vasorum have
been demonstrated in experimental vein grafts using silicone
rubber casts where luminally originating vasa vasorum in the
neointima were often visible along the suture line of the anas-
tomosis and distributed throughout the media and adventitia
and connecting to the original vasa (Ohta and Kusaba 1997).
These observations support earlier evidence of retrograde fill-
ing of vasa vasorum terminating within the vessel lumen
(Corson et al. 1985; Crotty 1989, 2003). A connection be-
tween the vasa vasorum and lumen has been demonstrated
in canine vein grafts where, in vivo, (luminal) endothelial in-
tegrity is maintained even in the absence of intraluminal blood
flow (Corson et al. 1985). In these studies it was shown that,
using intravenous fluorescein, blood flow through the vasa
vasorum supplies oxygen and nutrients to the entire vein wall
including the endothelium. These results suggest that the lu-
minal endothelium is supplied by nutrients directly via the
vasa vasorum rather than by diffusing through the deepest
layers of the media as previously stated by Brock (1977).
Classically, as oxygenated blood passes through the lumen
of arteries, the endothelium and VSMCs receive sufficient
oxygen and nutrients by diffusion thus, the role of the vasa
vasorum is less significant. However, in veins, the vasa
vasorum represents a microvessel network in the vessel wall
where its principle role is to supply blood to the wall as lumi-
nal oxygen and nutrient levels are low. Hence, the vasa
vasorum of veins penetrate closer towards the intima than
those of arteries and Bare seen to advantage in the thick walls
of the saphenous vein^ (Ham 1974). The importance of the
vasa vasorum in maintaining ‘healthy vessels’ is often
overlooked and these microvessels are damaged in various
forms of vascular surgery, in particular bypass procedures
for revascularization. The subsequent interruption of
transmural flow renders the vessel wall ischaemic, a condition
initiating many processes involved in graft occlusion. In ex-
perimental animal models it has been shown that occlusion of
the vasa vasorum by a close fitting external collar (Barker et
al. 1992, 1993), or adventitial removal (Barker et al. 1994),
results in neointimal hyperplasia and atherosclerosis, both
characteristics associated with mid- and long-term vein graft
failure.
Luminal termination of vasa vasorum?
Although the above mentioned studies provide some evidence
for vasa vasorum terminating in the vein lumen many, if not
the majority, of studies tend to disagree. This is clear from the
previously cited publication by Brock (1977), who maintains
the depth of penetration of the vasa vasorum through the me-
dia extends to within B36 μm of the endothelial layer [i.e. the
lumen] in a human long saphenous vein^, in support of earlier,
similar, statements (Wyatt et al. 1964). A number of ‘tracing’
studies have been reported using either India ink or vascular
corrosion casts to determine the 3 dimensional complex struc-
ture of the vasa vasorum in either varicose hSVs (Kachlik et
al. 2008) or hSVs obtained from patients undergoing
aortocoronary bypassing (Kachlik et al. 2007). Here, Fig. 2
demonstrates a representative example of vasa vasorum in
hSVobserved after corrosion of vascular casts. Certainly, the
3 dimensional distribution of vasa vasorum that are revealed
using scanning electron microscopy of resin casts are most
striking and provide the opportunity to illustrate the course
of vasa vasorum within the vessel wall as well as to calculate
certain morphometric variables such as vasa diameters,
branching distances and angles (Lametschwandter et al.
2004; Kachlik et al. 2007, 2008). In these studies, images
generated using India ink are less striking and less suitable
for quantitative assessment. The vascular bed of the lower
extremities of cadavers was also used that were injected 12–
24 h post mortem with India ink via the external iliac arteries
using manual pressure. The corrosion casting was performed
on segments of the middle or proximal hSV from patients
undergoing CABG. In all cases hSV segments for CABG
were taken with a thick layer of surrounding perivascular ad-
ipose tissue, whereby great care was taken to avoid any direct
mechanical contact with the vein to prevent artificial venous
constriction (essentially using the NTSVG harvesting
technique described by Souza 1996). Specimens (without
Fig. 2 Vasa vasorum of hSVobserved by scanning electron microscopy.
Note vascular corrosion cast of a spare segment of the proximal portion of
the hSV for CABG revealing the complex arrangement of vasa vasorum
from an adventitial view; arrows mark the feeding and/or draining vessels
infiltrating the SV every 0.5–1.5 cm. A = artery, V = vein. (Reproduced
from Lametschwandtner et al., Anat Rec 2004, Part A 281A:1372–1382
[Wiley-Liss, Inc.], which we gratefully acknowledge)
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any intraluminal washing and use of vasodilators) were stored
in ice-cooled heparinized saline and cast within 6–10 h after
harvesting and then examined under scanning electron
microscopy. Whilst the examples provided of corrosion casts
are impressive, Kachlik et al. (2007) comment that there are
likely to be a number of issues affecting the flow of the resin
due to its viscosity, which is around 5–10 times higher than
that of blood. Also, one should consider the effects of process-
ing and/or post-mortem delay as well as possible tissue shrink-
age. The time- and post-mortem-associated factors may limit
the access and flow of the tracers used and provide an inade-
quate impression of the network of the vasa vasorum in hSV
used for revascularization in CABG patients. A very recent
study from this group used standard histological techniques
to assess the distribution of vasa vasorum in walls of failed
aorto-coronary venous grafts (Stingl et al. 2018). Here, time-
related qualitative evaluation was performed on diseased hSV
grafts in an attempt to assess the extent of (neo)vascularization
related to graft pathology and re-grafting. While proliferation
of vasa vasorum from the adventitia to the outer layers of the
media were observed between 7 and 24 months after implan-
tation, proliferation throughout the entire atherosclerotic me-
dia and hyperplastic intima continued for a much longer time
interval. These observations therefore indirectly agree with the
well-established data that vasa vasorum play a central role in
the pathogenesis of atherosclerosis (Gingras et al. 2009;
Mulligan-Kehoe and Simons 2014; Boyle et al. 2017;
Sedding et al. 2018). Interestingly, Stingl et al. (2018) were
unable to identify luminal terminations of vasa vasorum in the
hSV samples studied. This is not surprising since most were
pathological samples of failed grafts with varying degrees of
neointimal hyperplasia or atherosclerosis. Furthermore, from
the appearance of the examples provided the hSV grafts had
been harvested with perivascular fat (PVF)/perivascular adi-
pose tissue (PVAT) removed using the CT, a situation that
causes significant histological and immunohistochemical
damage to the vasa vasorum (Ahmed et al. 2004; Dreifaldt
et al. 2011, 2013).
A recent study using India ink provides supporting evi-
dence for the luminal termination of vasa vasorum in the
hSV where this microvessel network extends from the vessel
lumen, courses through the media and adventitia to the capil-
laries within the vein’s surrounding cushion of PVAT. Here,
segments of hSV from patients undergoing CABG were per-
fused under normal cardiovascular conditions with India ink
via a cannula inserted in the lumen. Histological examination
of sections taken from these veins showed staining of the
luminal endothelium and the vasa vasorum throughout the
vessel wall and extending to the capillary network within the
PVAT (Fernández-Alfonso et al. 2016). Figure 3 demonstrates
a possible direct link between vasa vasorum and the lumen of
hSV harvested for CABG, while Fig. 4 shows the
Fig. 3 Possible luminal termination of vasa vasorum in NTSVG
preparations as examined with the scanning electron microscope (a, b)
and light microscope (c-e). a Note vasa vasorum (vv) in sections of vein
media (M). The venous ends (white arrow) of these vessels drained di-
rectly into the lumen (L); the black arrow points the direction of blood
flow. Original magnification ×70. (Modified from Souza et al., Scand J
Cardiovasc Surg 1999, 33(6):323–329 with acknowledgement of
Scandinavian University Press). b Showing a potential opening (4–
5 μm) of vasa vasorum within the vein luminal endothelium. Original
magnification ×3000. (Modified from Dreifaldt et al., J Thorac
Cardiovasc Surg 2011, 141(1):145–150 with acknowledgements of
Elsevier). c-e Transverse sections of NTSVG preparations perfused with
Indian ink (blue) show staining (arrows) at the lumen (L) as well as at
vasa vasorum within the adventitia (A) and perivascular adipose tissue
(PVAT); M =media. Original magnifications (c) ×95, (d, e) ×190. (c-e
Modified from Fernández-Alfonso et al., Curr Vasc Pharmacol 2016,
14(4):308–312 with acknowledgement of Dr. M. Dreifaldt and
Bentham Science Publishers Ltd)
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Bconcentration^ of vasa at the region of hSV intimal folds that
may reach the lumen.
In the light of the above data, the role of preserved/intact
vasa vasorum in hNTSVGs in CABG patients should be
recognised as Bbeneficial^ since physiological communica-
tion between intima, media, adventitia and PVAT remains un-
interrupted in such conditions (more on this subject in the
BVasa vasorum: vein versus artery^ section below).
However, it is important to stress that at present little is known
regarding the luminal termination of vasa in hSV used for
CABG. The most compelling evidence has been previously
described in canine SV, where it is known that such termina-
tions of vasa at the SV lumen can be opened by a complex
structure – the agger, which is sensitive to changes in blood
turbulence and conditions affecting flow through vasa
microvessels (see Crotty 2011).
Vasa vasorum in vivo: contribution
to saphenous vein graft performance
When harvesting the hSV conventionally for CABG, as de-
scribed by Favaloro (1969), the surrounding cushion of fat is
removed, the adventitia partially stripped and the SV
distended at high pressure to overcome the venospasm that
often occurs in response to surgical trauma. These procedures
cause tissue and/or cell damage to all vessel layers, damage
that affects graft patency (Ahmed et al. 2004; Vasilakis et al.
2004; Dashwood and Tsui 2013; Verma et al. 2014). In par-
ticular, regarding vascular damage, there is evidence, not only
of structural alterations to endothelial cells and VSMCs, but
also the constriction/collapse of some vasa vasorum and
‘clumping’ of erythrocytes (Ahmed et al. 2004; Dreifaldt et
al. 2011); Here, Fig. 5 demonstrates the above-mentioned fea-
tures of vasa vasorum in CT hSV that also display the pres-
ence of extravasated red cells (Fig. 5e) – a feature that may
contribute to vascular pathology (Nagy et al. 2010). Damage
to the vasa vasorum of conventionally harvested hSV is also
Fig. 4 Vasa vasorum in close proximity to the lumen of NTSVG. Note
red CD31-endothelial immunostaining concentrated close to the NTSVG
lumenal folds as seen in a circumferential section of the vein; Lu = lumen.
(Modified from Dashwood et al., Angiology 2004, 55(4):385–395 with
acknowledgement of SAGE Publishing, Westminster Publications, Inc.,
USA)
Fig. 5 Transmission electron microscopy of diverse features of vasa
vasorum in NTSV (a-c) and CTSV (d-e) graft preparations. Note the
open lumen in all vasa vessels in NTSV preparations (a-c); also note
the presence of red blood cells within the luminal space (Lu). In CTSV
preparations vasa are frequently collapsed or constricted so that the
luminal space is closed and not readily visible (d). In e note the damage
to a vasa vessel by CT harvesting; also note red blood cells outside the
vascular pool. In contrast, image f shows a rather well-preserved vessel.
Original magnifications: a, d × 5600; b, e, f × 2650; c, ×4400. (Modified
from Dreifaldt et al., J Thorac Cardiovasc Surg 2011, 141(1): 145–150
doi: https://doi.org/10.1016/j.jtcvs.2010.02.005, with acknowledgement
of Elsevier)
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observed using scanning electron microscopy (Fig. 6) where
‘disconnection’ of adventitial vessels/microvessels is evident
(Vasilakis et al. 2004). By contrast, where NTSVGs are re-
moved atraumatically and with minimal vascular damage, the
vasa vasorum remain intact with normal endothelial cell mor-
phology and VSMCs also maintaining a normal appearance
(Ahmed et al. 2004). Also, when using scanning electron mi-
croscopy, small openings were observed within the luminal
endothelial lining of the hSV (Fig. 3), openings taken to rep-
resent possible terminations of vasa vasorum, presumably ex-
tensions of the adventitial-medial microvessel network (Souza
et al. 1999; Dreifaldt et al. 2011). These features are likely to
have functional relevance since the filling of adventitial vasa
vasorum has been described in NTSVGs perfused with blood
from the arterial line of the cardiopulmonary bypass machine
before completion of the proximal anastomoses, or at comple-
tion of proximal anastomosis and removal of vascular clamps
during CABG (Souza et al. 2009; Dreifaldt et al. 2011). Here,
Fig. 7 demonstrates retrograde filling of NTSVG adventitial
vasa vasorum during CABG. Most importantly, data present-
ed above suggests that, at completion of graft insertion, retro-
grade (coronary) arterial blood flow occurs from the graft
lumen via the medial to the adventitial vasa vasorum, a situa-
tion that has been confirmed ex vivo on isolated segments of
NTSVG perfused with blood from the cardiopulmonary by-
pass machine (Souza et al. 2009; Dreifaldt et al. 2011).
Vasa vasorum: vein versus artery
It is well recognised that vasa vasorum of veins are more
pronounced than in arteries where oxygen and nutrients are
supplied by the luminal (arterial) blood. The vasa vasorum of
veins are classically described as being situated within the
adventitia and the media (Ham 1974) with some suggesting
these microvessels penetrate deep within the media and in
close proximity to the intima/lumen (Wyatt et al. 1964;
Brock 1977). The study described by Dreifaldt et al. (2011)
provides evidence for the luminal termination of vasa vasorum
in the hSV. Also, in this study the density, size and total area of
the vasa vasorum in the media and adventitia of transverse
histological sections was assessed by computer-assisted mor-
phometry comparing NTSVG with CT hSV grafts (Fig. 8).
While there was no significant difference between NTSVG
and CT hSV grafts regarding the density or size in these vessel
layers, there was a significantly greater total area in both the
media and adventitia of NTSVG compared with CT SV. A
similar, follow up, study was performed where the number
of vasa vasorum in the media and adventitia of NTSVG sec-
tions were compared with the media and adventitia of the ITA
and RA. Here, it was confirmed that the number of vasa
vasorum in the media and adventitia of NTSVGs was similar.
However, the number of vasa vasorum in these layers of
NTSVGs was significantly higher than of the ITA and RA
(Dreifaldt et al. 2013); see Fig. 9. In addition, this study pro-
vides quantitative support for the previously described ‘pene-
tration’ of vasa vasorum in veins versus arteries (Ham 1974)
where the number of vasa in the media were significantly
lower than in the adventitia of both the ITA and RA
(Dreifaldt et al. 2013). These results suggest that the vasa
vasorum are more important in maintaining transmural blood
supply in veins than in arteries and that, unlike arteries, this
high density microvascular network is sustained in the media
and approaches the lumen. Therefore it seems reasonable to
assume that preservation of an intact vasa vasorum in hSV for
CABG plays an important role in maintaining a healthy vessel
and consequently in improved graft performance. Conversely,
the damage to the vasa vasorum that occurs using CT harvest-
ing for CABG plays a significant role in the inferior perfor-
mance of the hSV when compared to the ITA.
The study by Loop et al. (1986) showed the ITA to have
significantly better patency than the hSV at 10 years (86%
versus 71% respectively). However, this data was obtained
on patients receiving CT hSV grafts. Subsequently, follow
up studies on patients receiving NTSVG and ITA grafts show
that NTSVGpatency is superior to hSV harvested convention-
ally at up to 16 years, with a patency comparable to the ITA
(Samano et al. 2015). Although other aspects of NTSVG, such
as preservation of PVAT (Dashwood et al. 2007, 2009, 2011)
and reducing damage to the luminal endothelium (Souza et al.
1999; Tsui et al. 2001, 2002) are important, hSV graft patency
is also improved by keeping the vasa vasorum intact and
maintaining transmural blood flow.
The advantages of the NTSVG technique is becoming
recognised and the technique adopted by an increasing num-
ber of cardiac centres worldwide. Indeed, the recent review by
deVries and colleagues (deVries et al. 2016) states BTherefore,
preservation of vein graft patency is essential for long-term
surgical success. With the exception of ‘no-touch’ techniques
Fig. 6 Scanning electron microscopy of conventionally harvested SV.
Note that the vasa vasorum vessels together with a part of adventitia are
partially detached from the vein wall and exposed to the external
environment. (Reproduced from Vasilakis et al., Vasc Dis Prev 2004,
1(2):133–139, with acknowledgement of Bentham Science Publishers
Ltd)
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and lipid-lowering and antiplatelet (aspirin) therapy, no inter-
vention has hitherto unequivocally proven to be clinically ef-
fective in preventing vein graft failure^. Noteworthy, here, is
the popularity of minimally invasive, endoscopic vein harvest-
ing (EVH) of the hSV for CABG in the USA where the ma-
jority of hSV are prepared by this procedure (Dacey et al.
2011). EVH was introduced more than two decades ago
(Lumsden et al. 1996) as a technique that reduces leg wound
complications, infection rate and pain and improves cosmesis.
Despite these benefits of EVH there is disagreement regarding
the patency of hSVs prepared by CT versus EVH where, at
best, patency of EVH grafts are ‘comparable’ to CT grafts
(Perrault et al. 2004; Yun et al. 2005). There are also conflict-
ing reports comparing EVH to CT harvesting on SVmorphol-
ogy. Some suggest there are no detrimental effects on vein
morphology, endothelial structure, or function (Fabricius et
al. 2000; Griffith et al. 2000; Black et al. 2001), that there is
better preservation (Nowicki et al. 2004) or no difference
(Griffith et al. 2000; Meyer et al. 2000) in endothelial integrity
between EVH and CT hSV grafts. While the majority of these
studies focus on damage to the endothelium, there are a few
histological examples showing marked damage to the adven-
titia of EVH hSV grafts (Nowicki et al. 2004; Kiani and
Poston 2011), a factor that seems to have been previously
overlooked. As with CT harvesting, the surgical trauma
caused using EVH, particularly to the outermost vessel layers,
is most likely to damage the vasa vasorum and have a delete-
rious effect on performance of hSV used as grafts in CABG
(for review see Kopjar and Dashwood 2016). The physiolog-
ical importance of vasa vasorum has recently been highlighted
by Boyle et al. (2017), who state, BThere is ample evidence
that dysfunctional vasa vasorum are directly involved in all
stages of atherosclerosis development, making them prime
candidates for therapeutic intervention^.
Indeed, several studies show that dysfunction of vasa may
stimulate a cascade of pathological processes involving mo-
lecular signalling leading in essence to atherosclerosis and
vascular disease (for review see Sedding et al. 2018); see
Fig. 10. Such a situation may arise during CT harvesting of
hSV where, when ‘stripping’ the adventitia, damage and a
substantial reduction in vasa occurs (Dreifaldt et al. 2011).
This reduction in vasa may eventually lead to re-
microvascularization of hSV CT graft adventitia (or rather
its remnant) in parallel with the increase of negative inflam-
matory processes leading to atherosclerosis. Therefore, as
Sedding et al. (2018) indicate, there is a growing interest in
the understanding of the role and consequences of microvas-
cular expansion in the vessel wall in both physiological and
pathophysiological circumstances (also see Gingras et al.
2009; Mulligan-Kehoe 2010; Mulligan-Kehoe and Simons
2014; Boyle et al. 2017). It seems reasonable to assume that
the disturbance/pathology of a functioning vasa vasorum also
applies to hSV conduits used for CABG, where damage (at
times severe) to the vasa microvascular system is inflicted
during CT harvesting. Therefore there is a high risk of devel-
oping hypoxic or ischaemic conditions in the hCTSV graft
wall (at least in the early stages after grafting) and initiating
Bharmful^ processes that affect graft patency. Indeed, the pre-
viously mentioned study of failed explanted aorto-coronary
hCTSV grafts showed that angiogenesis occurs after the graft
Fig. 7 Retrograde filling of
NTSVG adventitial vasa vasorum
during CABG – perfusion of
blood from cardiopulmonary
bypass via the lumen. a A vasa
vessel is not visible (in the area
indicated by arrows) due to the
occlusion by surgical forceps,
while in the b, the vasa vessel is
clearly seen when the occlusion is
released and blood flow is
restored. c-d Bleeding from an
incised adventitial vasa vasorum.
(Both screen shots from the video
in Dreifaldt et al., J Thorac
Cardiovasc Surg 2011, 141(1):
145–150, with
acknowledgements of Elsevier)
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was implanted to the coronary bed (Stingl et al. 2018).
Interestingly, increased linear proliferation of vasa vasorum
into the media and scattered within the intima can be observed
in the walls of thrombophlebitic hSVs likely to be influenced
by altered venous pressure and lack of oxygen (Chu et al.
2013). In relation to improving the outcome of hSV grafts in
CABG patients it seems more appropriate to use undamaged
hNTSVGs (Souza 1996), in preference to damaged
hCTSVGs; the latter frequently requires physical intervention
e.g. mechanical support using external stents (Murphy et al.
2007) or pharmacological intervention targeting vascular
growth factors (Pages and Pouyssegur 2005; Sedding et al.
2018).
In the recent article published in the New England Journal
of Medicine the RADIAL investigators, an international
group of cardiologists and cardiac surgeons, reported a
patient-level combined analysis of randomized, controlled
trials to compare RA and hSV grafts for CABG in over
1000 patients. The results of this analysis showed there to be
an inferior patency of hSV coronary grafts compared to RA
grafts as well as a nominally lower incidence of myocardial
infarction and a lower incidence of repeat revascularization
(Gaudino et al. 2018). However, in this study the details of
graft harvesting procedure were not discussed in any detail
and we presume that hSV grafts were routinely harvested by
CTand therefore likely to have been stripped and distended at
the time of CABG surgery. While the mean follow-up time in
the RADIAL investigator study was 50 ± 30 months it is note-
worthy that the long-term patency of hSVs were superior to
the RA (Dreifaldt et al. 2011) and comparable with ITA grafts
(Samano et al. 2015) over a longer follow up period when
NTSVGs were used. As vascular researchers we believe there
is a worrying trend whereby minimal details of harvesting
procedure are provided in many cases with no apparent con-
sideration regarding the effects of vascular damage on graft
performance. Indeed, comparing CT with NTSVGs may be
said to be like Bmixing apples with oranges^, a term recently
used to criticise the inclusion criteria of certain meta-analyses
(Milojevic et al. 2018). While the important role of the endo-
thelium and endothelium-derived factors in graft patency is
well-established, ‘mechanical’ damage, due to handling by
surgical instruments and/or traction (eg when using EVH) as
well as by distension (Souza 1996; Ahmed et al. 2004), to
other vascular structures is often overlooked. When hSV are
harvested by CT the vasa vasorum is severely damaged, dam-
age likely to initiate the processes of atherosclerosis and graft
occlusion associated with the poor performance of this con-
duit, particularly when compared with the superior patency of
the ITA. If hSVs are prepared as NTSVGs normal vessel struc-
ture is maintained, a functioning vasa vasorum is preserved
Fig. 9 Quantitative assessment comparing vasa vasorum density in
bypass conduits from patients undergoing CABG surgery. Note
dominant vasa vasorum density in SV adventitia (SVA) and SV media
(SVM) as compared to internal thoracic artery adventitia (ITA) and media
(ITM), as well as radial artery adventitia (RAA) and media (RAM).
(Adapted from Dreifaldt et al., Angiology 2013, 64(4):293–9. doi:
https://doi.org/10.1177/0003319712443729. Epub 2012 May 7, with
acknowledgement of SAGE Publishing, Westminster Publications, Inc.,
USA)
Fig. 8 Quantification of vasa vasorum. Representative transverse
sections of no-touch (NT) and conventionally harvested (CT) hSV
segments from a CABG patient used for quantification of CD34-
immunolabeling (brown stain) of endothelial cells identifying the vein’s
vasa vasorum; A = Adventitia; M =media. Bar = 0.5 mm. (Modified
from Dreifaldt et al., J Thorac Cardiovasc Surg 2011, 141(1):145–150,
with acknowledgement of Elsevier)
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and transmural blood supply restored. Consequently, oxygen-
ated arterial blood may be retrogradely delivered from the lu-
men of the graft where the vasa may play a protective role in
protecting the graft wall against ischemia (Souza et al. 2006;
Dreifaldt et al. 2011). Furthermore, an intact vasa vasorum
may potentially affect graft performance by allowing bidirec-
tional delivery of cell- or tissue-derived signalling molecules
throughout the vessel wall.
Vasa vasorum and hypoxia
Throughout this review we stress the importance of the vasa
vasorum in relation to the preservation of the oxygen supply to
the wall of SV grafts and the maintenance of communication
between intimal, medial and adventitial components/cells via
blood flow in this microvascular network. The involvement of
the vasa vasorum in normal versus pathological blood vessels
has mainly focussed on arteries, particularly in conditions
where blood flow is reduced due to narrowing of the lumen
caused by intimal hyperplasia or atherosclerosis. In their re-
view on this subject, Ferns and Heikal (2017) discuss the
anoxemia theory where a key factor in the development of
atherosclerosis is suggested to be due to an imbalance between
the demand and supply of oxygen in the arterial wall. In par-
ticular the authors mention hypoxia-inducible factor (HIF-1)
1α and its important role as ‘a master regulator of oxygen
homeostasis’. Apart from being associated with VSMCs and
inflammatory regions of atherosclerotic plaque HIF-1 is also
located to perivascular tissues where it regulates certain genes
involved in vascular function including vascular endothelial
growth factor (VEGF), nitric oxide synthase (NOS) and
endothelin. Thirty decades ago elegant ‘cinematographic’
studies on post-mortem atherosclerotic coronary arteries re-
vealed microvessels growing from native vasa vasorum and
extending from the adventitia to the thickened intima of ath-
erosclerotic vessels (Barger et al. 1984; Kamat et al. 1987). In
more advanced lesions such neovascularization may be seen
as an important, beneficial, process in restoring blood flow,
and therefore oxygen supply, to the vessel wall. Such new
vessel growth/ neoangiogensis is now known to occur in re-
sponse to physical stimuli such as shear stress and hypoxia
involving angiogenic growth factors that are regulated by
HIF-1 include angiopoietin 2 (ANGPT-2), placental growth
factor (PLGF), stem cell factor (SCF), stromal cell-derived
factor 1 (SDF-1), and platelet-derived growth factor B
(PDGF-B) (Semenza 2010). Also, under hypoxic conditions
there is increased synthesis of heparan sulphate in microvas-
cular endothelial cells which has been shown to stabilize the
vasa vasorum and to promote endothelial cell growth
(Mollmark et al. 2012) via fibroblast growth factor 2 (FGF-
2) receptors (Li et al. 2002).
Whereas the majority of studies relating to the effect of
hypoxia in vessel pathology have been mostly on arteries,
some have also included hSV material. The importance of
maintaining blood and oxygen supply to all layers of the
vessel wall has recently been supported by an elegant ex
vivo culture system using hSV (Piola et al. 2016). This
culture system, employing excess hSV material from pa-
tients undergoing CABG, provides the ability to generate
an oxygen gradient between the luminal and adventitial
sides, thereby mirroring the conditions observed in
healthy, intact hSV. There is strong evidence that adven-
titial hypoxia (that may occur in CT hSV grafts) stimu-
lates the process of neo-vascularization of the vasa
vasorum, which subsequently predisposes arterialized
hSV conduits to restenosis (Cox et al. 1991; Piola et al.
2016). We might therefore consider the possibility that
varying oxygen concentrations may have different effects
on the luminal hSV endothelium than on the ‘microvascu-
lar endothelium’ of the vasa vasorum. For example, it is
well established that the vasa vasorum of intact hSV is
supplied by both arterial and venous blood (Kachlik et
al. 2003, 2007; Lametschwandtner et al. 2004), hence
the endothelium of vasa vessels is exposed to varying
concentrations of oxygen. Thus, the vasa vasorum repre-
sents a heterogenous system of vessels/microvessels po-
tentially able to differentially respond, either physiologi-
cally or pathophysiologically, to changes in oxygen con-
centration. Since this microvessel system is damaged/
Fig. 10 A highlight of pathological formation of adventitial vasa
vasorum. Note the events involving, among others, adhesion molecules,
leukocytes, inflammatory cells, cytokines, low-density lipoproteins
(LDL) or pro-angiogenic factors participating in neo-angiogenesis,
leading to eventual projection of neovessels to the media and subintima.
(A fragment of Fig. 1 from Sedding et al. (2018), Front Immunol Apr
17;9:706. doi: https://doi.org/10.3389/fimmu.2018.00706. ECollection
2018, which we gratefully acknowledge)
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interrupted in, ‘traditional’, CT hSVGs it is prone to path-
ological sprouting (neovascularization) towards the SV
lumenal intima, potentially transporting cholesterol, in-
flammatory cells, erythrocytes, extracellular matrix and
other proatherogenic molecules to the lumen involved in
plaque formation and graft occlusion (Sedding et al.
2018). In fact, controversy remains as to the effects that
oxygen may have on the vasa vasorum. For instance, it is
suggested that stripping of varicose hSV reduces local
production of harmful reactive oxygen metabolites
(ROM) resulting in a positive effect on vein physiology
(Flore et al. 2003). Furthermore, according to Joddar et al.
(2015), the higher arterial levels of oxygen and elevated
level of reactive oxygen species (ROS) stimulates intimal
hyperplasia in hSV organ culture models where the hSVs
were harvested by standard endovascular techniques.
However, data from such in vitro organ culture studies
(14 days in the medium, changed every 2 days; some
culture medium also containing compound tiron to help
reoxygenation) may be limited and may not reflect the
true physiological events that occur in vivo hSV when
used in CABG patients.
A porcine model of SV into artery interposition
grafting has been described where the effect of external
synthetic stents and sheaths on vein graft remodelling and
thickening have been studied (Violaris et al. 1993). It was
shown that the placement of a loose-fitting external poly-
ester stent reduced long-term medial and neointimal thick-
ening and platelet derived growth factor (PDGF) expres-
sion in this pig model of arteriovenous bypass grafting
(Mehta et al. 1998). Here the development and promotion
of a neoadventitia in the space between the graft and the
stent occurred which allows for the development of
microvessels from the native vasa vasorum that Bmay ob-
viate graft wall hyperplasia through the prevention of
graft hypoxia^ (Jeremy et al. 2007). In their review on
data obtained using this porcine/external stent model the
authors state Bremoval of the saphenous vein, ipso facto,
results in a loss of continuity of the vasa vasorum, a
microvessel complex that infiltrates and oxygenates large
blood vessels which in turn would result in hypoxia of the
tissue^ continuing, BDisruption of the vasa vasorum, per
se, is associated with vascular disease and upregulates the
expression of literally hundreds of proteins that include
those that promote vein graft disease^ (Jeremy et al.
2007) . In teres t ingly, us ing this porcine model ,
endothelin-1 and its receptors and nitric oxide synthase
– both endothelium-derived factors affected by hypoxia
and both affecting vessel growth – are located on vasa
vasorum and regions of neovascularization of pig SV
grafts (Jeremy et al. 1997, 1998; Wan et al. 2004).
While a considerable amount of data has been pub-
lished regarding the role of the vasa vasorum in
pathological conditions in human arteries, in particular
the epicardial coronary arteries, there is less information
available on the SV. Reducing medial blood flow and
oxygen supply by occluding the vasa vasorum in arteries
causes neointima formation and atherosclerosis via the
action of a vast number of hypoxia-induced factors.
Since the role of the vasa vasorum in providing oxygen
to the wall of the SV is more important than in arteries it
seems reasonable to assume that anything reducing blood
flow through this microvessel network will produce sim-
ilar, or more serious, consequences. The considerable
damage caused to the vasa vasorum when using CT har-
vesting described in earlier sections of this review will
reduce medial blood flow stimulating a plethora of
hypoxia-induced factors involved in vein graft failure
(Fig. 11). If the vasa vasorum remains intact, medial
blood flow and oxygen supply is maintained and vein
graft patency is improved dramatically as shown using
the NTSVG (Souza et al. 2006; Samano et al. 2015).
According to the recent review by Sedding et al. (2018)
B…therapeutic approaches specifically targeting the
expanding microvessels in developing plaques will have
to be established and evaluated^. Rather than ‘expanding
microvessels’ it would seem more logical to harvest the
hSV in CABG in a way that preserves an intact, function-
ing vasa vasorum where no therapeutic intervention
would be required.
Fig. 11 Proposed reduction in blood flow in damaged vasa vasorum:
medial hypoxia. Top panel: No-touch harvested hSV where the
adventitia and vasa vasorum are intact. Blood flow to the vein wall is
restored after graft implantation: oxygen and nutrient supply is
maintained. Lower panel: Diagram of a conventionally harvested hSV
where the adventitia has been stripped off or damaged during harvesting.
The vasa vasorum constrict or are occluded. Blood flow to the vein wall is
reduced releasing hypoxic factors as described in the text. Such factors are
associated with many aspects of graft failure including neointimal
thickening and atherosclerosis
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Conclusions
The vasa vasorum of the hSV plays a more important role in
providing oxygen and nutrients to the vessel wall than in ar-
terial bypass grafts, the ITA and RA. Consequently, this mi-
crovascular network is more prolific in the SV than the ITA or
RA and extends deeper in the media with some evidence of
terminations in the lumen. Furthermore, the connection of
vasa vasorum to capillaries within the PVAT surrounding the
hSV suggests that, apart from supplying blood, this microvas-
cular network may potentially transport tissue- and/or cell-
derived factors from the outermost to the innermost layers of
this blood vessel or vice versa. The damage caused to the vasa
vasorum of the hSV during conventional harvesting in CABG
reduces transmural blood supply, a situation that promotes
neointimal hyperplasia and atheroma formation, features as-
sociated with mid- and long-term graft patency. If the hSV is
harvested with minimal vascular trauma, the vasa vasorum
remains intact and arterial blood flow is restored at completion
of graft insertion. In addition, an intact vasa vasorum may
provide a system for the transport of factors and cell to cell
communication across the hSV graft wall that are beneficial to
improved graft performance.
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